freephone 0800 862 0373
Sign in to view your quotes
Email address:
Password or PIN:

Forgotten your password? Reset it here.

Revolutionary skin cancer drug Zelboraf now available through private medical insurance

Published on 29/03/2012

A drug for patients with advanced skin cancer went on sale in Britain for the first time this month, after doubling survival time in international trials. But whilst drug Zelboraf will not be assessed for use on the NHS until October, people with private medical insurance could have access to the drug on their policy straight away.

Melanoma is a form of advanced skin cancer that kills around 2,000 people in the UK each year. Whilst melanoma is rare, it is also aggressive and dangerous, and can spread quickly to other organs in the body in a process called metastasis.


Skin cancer drug Zelboraf is available through private medical insurance

Normally, patients suffering from metastatic melanoma do not live for longer than nine months. But new drug Vemurafenib, marketed by drugs firm Roche as Zelboraf, has been shown to increase life expectancy to an average of 16 months, as well as significantly improving quality of life.

Although Zelboraf is only suitable for around half of melanoma patients- those with a mutated form of the BRAF gene- it is the first major medical advance in this field for over 30 years. Dr Paul Nathan, a consultant medical oncologist at the Mount Vernon Cancer Centre, said:

"This drug makes a massive difference compared to what we’ve had before. We've never seen anything like it."

Due to its success in international trials, Zelboraf has been awarded a European license and can now be prescribed in the UK. But as with all new drugs, it needs to be approved by the National Institute for Health and Clinical Excellence (NICE) before it becomes widely available on the NHS. This approval process takes a significant period of time, and a decision on Zelboraf will not be made until October 2012.

Private medical insurance gives patients access to licensed drugs like Zelboraf regardless of whether or not they are available on the NHS. Dr Katrina Herren, Medical Director at Bupa Health and Wellbeing, explained: “If a cancer drug is licensed by the European Medicines Agency (EMA) and is being used within license, we will fund it regardless of cost.”

Bupa is not the only health insurer that will cover licensed drugs like Zelboraf. Aviva, AXA PPP and PruHealth are just a few of the other insurers in the UK that offer comprehensive cancer cover with no limits. With more and more cancer drugs being developed each year, it might be wise to compare health insurance policies online.

© ActiveQuote Ltd. 2012


Categories:  Health InsuranceMedical
Revolutionary skin cancer drug Zelboraf now available through private medical insurance A drug for patients with advanced skin cancer went on sale in Britain for the first time this month, after doubling survival time in interna    tweet it on twittershare with your friends on Facebookshare with your friends on MySpaceBlog it on your LinkedIn profile
 

No.1 health insurance broker as rated by customers

Excellent service. Explained everything in detail and really helped to find the right insurance best suited to my needs - which wasn't necessarily the most expensive. 

Review centre member

Good value and the advisor was very helpful and recommended the best policy for my grandson. I would definitely use this service again and recommend to others.

Review centre member

We were contacted in good time to make a knowledgable choice. We were given plenty of options with lots of information to enable us to make the right choice.

Review centre member

The service I received was excellent, the staff member was very efficient and knowledgable. She went out of her way to get the best policy for me.

Review centre member

Great service. I really appreciated the help provided by Active Quote to arrange health insurance. The agent was very informative and proactive. Many thanks!

Review centre member

I received excellent care and attention from the first phone call till the last. Friendly, efficient and patient.

Review centre member

Staff are very helpful, friendly and polite. They call back when they say they will and keep you up to date with progress. Pleasure to deal with.

Review centre member

Very polite and friendly, and gave detailed explanations of all aspects of the cover. Reassuring to know that if you do have a problem there is someone you can contact.

Review centre member

Friendly and efficient. Nothing was too much trouble even when i needed to make a small change, excellent service.

Review centre member

The advisor was incredibly helpful and fully explained the differences between the policies. I really liked the fact that I was put under no pressure.

Review centre member
 
This site is operated by Insurance Broker ActiveQuote Ltd registered in England & Wales company number 6765845.
Authorised and Regulated by the Financial Conduct Authority (FCA). Firm reference number 501109 as detailed on the Financial Services Register. Please read our Key Facts document.
For information about your rights as a consumer visit Citizens Advice.

Our insurance comparison service is free and easy for you to use, but you are responsible for making sure all your information is entered correctly, and for choosing your insurer.

This site uses cookies in order to work correctly - these are not harmful and do not contain personal information. By using this site you consent to this. I understand  Tell me more

please wait ...